Steve Warnecke, President of CereHealth Corp., parent company of CereScan®, will be presenting the company’s brain data analytics platform, CereMetrix® at the World Entrepreneur Forum in Vancouver, BC on July 14, 2017.
The conference, hosted by Venture Development Canucks in partnership with UBC, is focused on “Finding the Next Edison” through its invitation to fast growth innovative companies with cutting edge technologies, who will be presenting to international venture capitalists and business strategists.
CereMetrix® is a brain-focused medical analytics platform that may accelerate the accurate and effective diagnosis of complex brain-related disorders to improve treatment and outcomes for patients.
“The opportunity to present our story and CereMetrix’s evolution at the World Entrepreneur Forum is an important step in gaining international exposure and access to global markets through an audience of recognized business leaders and strategists,” expressed Mr. Warnecke. “I’m honored to have been invited, and excited to explore business development opportunities with this esteemed group of Canadian and multi-national trailblazers in business and innovation.”
CereScan® combines state-of-the-art brain imaging technologies with a patient-centered model of care to provide the highest level of neuro-diagnostics available. CereScan® utilizes state-of-the-art gamma camera technology, new generation imaging software and a proprietary process to produce comprehensive medical reports including voxel level images of brain function and physiology. Our functional brain imaging technologies are the most sophisticated in the world today. Additional information about the company is available at https://cerescan.com.
CereScan® and CereMetrix® are registered trademarks of CereHealth Corp.